Panzem Nanocrystal Colloidal Dispersion (NCD)
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ovarian Cancer
Conditions
Ovarian Cancer
Trial Timeline
Oct 1, 2006 → Nov 1, 2008
NCT ID
NCT00400348About Panzem Nanocrystal Colloidal Dispersion (NCD)
Panzem Nanocrystal Colloidal Dispersion (NCD) is a phase 2 stage product being developed by CASI Pharmaceuticals for Ovarian Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00400348. Target conditions include Ovarian Cancer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00400348 | Phase 2 | Completed |
Competing Products
20 competing products in Ovarian Cancer